Sharemaestro Newsreel

American Century group reports 5.4% Emergent BioSolutions (EBS) ownership on Schedule 13G

American Century ETF Trust and its affiliates, including American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research, have reported passive ownership stakes in Emergent BioSolutions Inc. (EBS) common stock via a Schedule 13G filing. The ETF Trust …

Assembly Biosciences (NASDAQ:ASMB) Trading Up 8.2% on Strong Earnings

Assembly Biosciences (NASDAQ:ASMB) saw its shares rise by 8.2% after reporting better-than-expected quarterly earnings, with a loss of $0.20 per share against an anticipated $0.72 loss and revenue of $13.37 million surpassing estimates of $8.60 million. Analysts have a "Moderate Buy" consensus rating with …

Goldman Sachs Group (TNGX) discloses 6.0% beneficial stake in Tango Therapeutics

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have disclosed a 6.0% beneficial ownership stake in Tango Therapeutics, Inc. (TNGX) through a Schedule 13G filing. This holding amounts to 9,742,402.80 shares and signifies shared voting and dispositive power over …

Twist Bioscience (TWST): ARK Investment Management reports 4.55M-share, 7.31% stake

ARK Investment Management LLC and its founder Catherine D. Wood have reported a beneficial ownership of 4,549,803 shares of Twist Bioscience Corp (TWST) common stock, representing 7.31% of the company's class. The filing, a Schedule 13G/A, indicates that ARK has sole voting power over …

Will Pennant’s Higher 2026 Guidance and Tucson Acquisition Change Pennant Group's (PNTG) Narrative

The Pennant Group (PNTG) reported strong Q2 2026 results with increased sales and net income, along with higher 2026 revenue guidance of US$1.17 billion to US$1.19 billion. The company also expanded its senior living portfolio by acquiring the River Centre Assisted Living community in …

Heartflow, Inc. Stock 12‑Month Price Target Raised to $43.5, Implies 40% Upside

Heartflow, Inc.'s stock 12-month price target has been increased to $43.5 from $36.62, representing a 40% potential upside based on its closing price on August 13. This revised target comes from estimates by 8 analysts, with forecasts ranging from $39 to $45 per share. …

Canopy Growth’s Kincardine Facility Secures EU-GMP Recertification

Canopy Growth's Kincardine, Ontario facility has received renewed EU-GMP certification from a German authority, critical for exporting medical cannabis to Germany. This recertification highlights the facility's quality and reliability, supporting Canopy Growth's expanding presence in the European market. The Kincardine facility, a 440,000-square-foot greenhouse, …

Kura Oncology (NASDAQ:KURA) Stock Price Up 8% on Analyst Upgrade

Kura Oncology (NASDAQ:KURA) saw its stock price rise 8% following an analyst upgrade from Wedbush, which increased its price target to $38 from $36 while maintaining an "outperform" rating. The company's Q2 results surpassed expectations with a narrower loss and higher revenue, driven by …

Why Oscar Health (OSCR) Stock Is Up Today

Molina Healthcare (MOH) Is Up 7.2% After Strong Q1 Results And Clearer Medicaid Funding Outlook

Cardinal Health CEO details M&A strategy and growth

Jason Hollar, Cardinal Health (CAH) CEO joins Yahoo Finance Executive Editor Brian Sozzi to detail how M&A strategy, specialty pharma growth, and drug volume dynamics are driving profits. Video Transcript 00:00 Speaker A Where do you want to take this business with acquisitions? 00:02 …

ImmuCell Corporation 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:ICCC) 2026-08-14

Why (TIL) Price Action Is Critical for Tactical Trading

This article analyzes Instil Bio Inc. (NYSE: TIL) using AI models to suggest trading strategies based on price action. It identifies neutral readings in shorter horizons, potentially signaling an easing of a long-term weak bias, and highlights compelling upside potential with no remaining resistance …

Kestra Medical Technologies (KMTS) Nears Its Fair Value, Is The Stock Already Fully Valued?

Kestra Medical Technologies (KMTS) has seen recent positive share price momentum, with its stock closing at US$27.74. While a common narrative suggests the stock is undervalued with a fair value of $28 based on ambitious growth assumptions, other metrics like the P/S ratio indicate …

Liquidity Mapping Around (SRZN) Price Events

The article provides a detailed analysis of Surrozen Inc. (NASDAQ: SRZN) stock, highlighting strong sentiment across all horizons and an exceptional 86.7:1 risk-reward setup. It outlines three distinct AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored for different risk profiles and holding periods, along …

Lantern Pharma (LTRN) Advances AI-Driven Oncology Pipeline Amid Valuation Challenges

Bionano Genomics (BNGO) investor discloses 9.9% position via warrants

CVI Investments, Inc. and Heights Capital Management, Inc. have disclosed a 9.9% beneficial ownership in Bionano Genomics (BNGO) through warrants. This position, amounting to 1,307,135 shares, is subject to ownership caps of 4.99% and 9.99% for different portions of the warrants. The ownership percentage …

AN2 Therapeutics (ANTX) director reports gift of 405,880 shares and 145,538 held

AN2 Therapeutics director Joseph S. Zakrzewski reported a bona fide gift of 405,880 shares of common stock, which were previously held indirectly through the Z3 Trust. He disavows beneficial ownership of these gifted shares. Following this transaction, Zakrzewski directly holds 145,538 shares of AN2 …

CVRx, Inc. (CVRX) investor Jorey Chernett discloses 5.5% beneficial stake

Investor Jorey Chernett has disclosed a 5.5% beneficial ownership stake in CVRx, Inc. (CVRX), holding 1,461,750 shares of common stock. This ownership grants Chernett sole voting and dispositive power over these shares, based on CVRx's 26,641,597 outstanding shares as of July 30, 2026. The …

Waystar Holding Corp. (WAY) awards 162,112 RSUs to Chief Financial Officer

Waystar Holding Corp. (WAY) has granted 162,112 restricted stock units (RSUs) to its Chief Financial Officer, Alpana Wegner, on July 24, 2026. These RSUs will vest over time, with 6.25% vesting quarterly during the first year and 25% annually thereafter until July 22, 2030, …

Cormorant Asset Management (CABA) discloses 10M-share Cabaletta Bio stake

Cormorant Asset Management, LP and Bihua Chen have disclosed a 5.95% beneficial stake in Cabaletta Bio, Inc. (CABA), totaling 10,000,000 shares. This stake comprises 5,000,000 common shares and warrants to purchase an additional 5,000,000 shares, with both parties holding shared voting and dispositive power. …

Praxis Precision Medicines (PRAX): Orbis, Allan Gray disclose 5.5% ownership stake

Orbis Investment Management Ltd and Allan Gray Australia Pty Ltd have jointly disclosed a 5.5% ownership stake in Praxis Precision Medicines (PRAX), amounting to 1,529,788 shares of common stock as of June 30, 2026. Orbis holds the majority with 1,526,680 shares, while Allan Gray …

UBS Maintains Schrodinger(SDGR.US) With Hold Rating, Maintains Target Price $19

UBS has reiterated its Hold rating on Schrodinger (SDGR.US) and maintained its target price at $19. This indicates that the firm does not anticipate significant upward or downward movement for the stock in the near term, based on its current analysis.

Artivion (AORT): Nomura entities report 6.5% beneficial stake in 13G/A

Nomura Asset Management International Inc. and Nomura Investment Management Business Trust have reported a combined 6.5% beneficial ownership in Artivion, Inc., totaling 3,184,974 shares of common stock. This filing, a Schedule 13G/A, indicates shared voting and dispositive power over these shares, calculated based on …

Cormorant Asset Management (BIOA) discloses 5.38% BioAge Labs ownership stake

Cormorant Asset Management, LP and Bihua Chen have disclosed a 5.38% beneficial ownership stake in BioAge Labs, Inc. (BIOA), as reported in an amended Schedule 13G filing. This ownership amounts to 2,390,605 shares of common stock, with both shared voting and dispositive power. The …

Kaplan Fox Investigates Fulcrum Therapeutics After 51% Stock Plunge Following Pociredir Program Halt

Kaplan Fox & Kilsheimer LLP has initiated an investigation into Fulcrum Therapeutics (NASDAQ: FULC) following a 51% stock drop. The plunge occurred after Fulcrum unexpectedly halted its pociredir program for sickle cell disease due to FDA concerns over its benefit-risk balance. The investigation will …

Neumora Therapeutics Releases Q2 2026 Financial Results

Neumora Therapeutics (NMRA) reported a diluted loss per share of $0.23 for Q2 2026, representing a net loss of $43.1 million. The clinical-stage biopharmaceutical company narrowed its per-share loss by 30.3% year-over-year compared to Q2 2025. This performance is typical for biopharma companies in …

Spruce Biosciences (SPRB) sees AWM Investment disclose 5.1% equity stake

Cormorant Asset Management (ANL) discloses 3.98M Adlai Nortye ADS position

Is Alcon (SWX:ALC) Below Fair Value On Mixed Earnings And RxSight News?

Luigi Mangione Pleads Guilty in US Case Over CEO Killing

Luigi Mangione pleaded guilty in a federal case over the fatal shooting of UnitedHealth Group executive Brian Thompson in December 2024. View Comments

Bleichroeder (MDXH) reports 31.6M-share, 33.2% holding in MDxHealth

Bleichroeder LP and related parties have reported a 33.2% beneficial ownership in MDxHealth SA, totaling 31,648,563 Ordinary Shares. This significant stake was accumulated for investment purposes, including a recent purchase of over 24 million shares in a registered direct offering at $0.454 per share …

U.S. Physical Therapy (NYSE:USPH) Trading Down 4.8% - Here's Why

Mangione Admits to Killing Healthcare CEO Brian Thompson

Luigi Mangione pleaded guilty to federal stalking charges related to the fatal shooting of UnitedHealth Group Inc. executive Brian Thompson. Mangione admitted on Friday in New York federal court that he shot and killed Thompson on Dec. 4, 2024. He faces life in prison. …

OptimizeRx Corp (OPRX) gains 6.7% institutional holder in Kennedy Capital

Kennedy Capital Management LLC has reported a beneficial ownership of 1,248,899 shares of OptimizeRx Corp (OPRX) common stock, representing a 6.7% stake. The firm, based in St. Louis, Missouri, holds sole voting and dispositive power over these shares, establishing itself as a significant institutional …

Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase

Three Pfizer insiders executed transactions directly on the heels of the drugmaker’s second-quarter earnings report. Continue Reading